Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nikolaos Zacharakis"'
Autor:
Yong Li, Steven A Rosenberg, Paul F Robbins, Zhiya Yu, Maria Parkhurst, Billel Gasmi, Nikolaos Zacharakis, Todd D Prickett, Jared J Gartner, Sri Krishna, Stephanie L Goff, Satyajit Ray, Frank J Lowery, Sivasish Sindiri, Alakesh Bera, Noam Levin, Sanghyun P Kim, Charles A Marquardt, Nolan R Vale, Lior Levy, Tiffany Benzine, Robert V Masi, Rafiqul Islam
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 5 (2024)
Background Tumor-infiltrating lymphocytes (TILs) targeting neoantigens can effectively treat a selected set of metastatic solid cancers. However, harnessing TILs for cancer treatments remains challenging because neoantigen-reactive T cells are often
Externí odkaz:
https://doaj.org/article/f685ba7746d3429ab6dd6d6e8a83fc10
Autor:
Steven A Rosenberg, Maria Parkhurst, Paul Robbins, Nikolaos Zacharakis, Frank Lowery, Sri Krishna, Rami Yoseph, Neilesh Parikh, Sivasish Sindiri, Kyle J Hitscherich, Noam Levin, Aaron Dinerman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/af95ef9b755540c2b0c0694eee5dfd28
Autor:
Steven Rosenberg, Maria Parkhurst, Paul Robbins, Nikolaos Zacharakis, Frank Lowery, Sri Krishna, Rami Yoseph, Neilesh Parikh, Praveen Chatani, Yong-Chen William Lu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/d1cbd8b9e12d4103b96e69ab5bb825b8
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/5d5f60e3d0864f85915507f3c5531a6c
Autor:
Yong-Chen William Lu, Frank J. Lowery, Rami Yoseph, Maria R. Parkhurst, Praveen D. Chatani, Neilesh Parikh, Nikolaos Zacharakis, Steven A. Rosenberg, Sri Krishna, Paul D. Robbins
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundAutologous patient T cells engineered to express antitumor T cell receptors (TCRs) and chimeric antigen receptors (CARs) have been effective for the treatment of certain cancer types,1–4 and tumor neoantigens encoded by cancer-specific mu